Wockhardt planning to roll out two vaccines within year from UK-based facility

27 Feb 2023 Evaluate

Wockhardt is planning to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute of India. Last year, a Wockhardt unit tied up with a subsidiary of Serum Institute of India to set up a vaccine manufacturing facility in Wrexham, North Wales (UK).

Serum has identified two vaccines and the company plans to manufacture these products within the next 12 months after exhibit batches and regulatory approval is received.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1429.20 33.15 (2.37%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×